Importance of Patient History and Physical Examination in Rheumatoid Arthritis Compared to Other Chronic Diseases: Results of a Physician Survey

Size: px
Start display at page:

Download "Importance of Patient History and Physical Examination in Rheumatoid Arthritis Compared to Other Chronic Diseases: Results of a Physician Survey"

Transcription

1 Arthritis Care & Research Vol. 64, No. 8, August 2012, pp DOI /acr , American College of Rheumatology BRIEF REPORT Importance of Patient History and Physical Examination in Rheumatoid Arthritis Compared to Other Chronic Diseases: Results of a Physician Survey ISABEL CASTREJÓN, 1 LAUREN MCCOLLUM, 1 MINE DURUSU TANRIOVER, 2 AND THEODORE PINCUS 1 Objective. To survey physicians opinions concerning the relative importance of 5 clinical encounter components vital signs, patient history, physical examination, laboratory tests, and ancillary studies in the diagnosis and management of 8 chronic diseases. Methods. A SurveyMonkey internet survey was ed to 7,265 US physicians, including 3,542 rheumatologists and 3,723 nonrheumatologists, with the following query: Please indicate the relative importance of 5 sources of information vital signs, patient history, physical examination, laboratory tests, and ancillary studies in diagnosis of congestive heart failure (CHF), diabetes mellitus, hypercholesterolemia, hypertension, lymphoma, pulmonary fibrosis, rheumatoid arthritis (RA), and ulcerative colitis. The response options were 0 20%, 21 40%, 41 60%, 61 80%, and %. A second query with an identical structure addressed management of the 8 diseases. The proportions of physicians who estimated each component as most (or tied for most) important in diagnosis or in management were computed. Results. The survey was completed by 313 physicians (154 rheumatologists and 159 nonrheumatologists). More than 90% estimated vital signs as most important for hypertension, and laboratory tests for diabetes mellitus and hypercholesterolemia. More than 70% estimated ancillary studies as most important for lymphoma, pulmonary fibrosis, and ulcerative colitis. Patient history and physical examination were estimated as most important for RA and CHF by >50% of nonrheumatologists. Conclusion. RA and CHF were the only 2 of the 8 diseases studied for which >50% of nonrheumatologists estimated a patient history and physical examination as most important for diagnosis and management. Confirmation and extension of these observations in actual care may have implications for reimbursement and organization of clinical care. Introduction A clinical encounter between a patient and physician may include 5 components: vital signs, patient history, physical examination, laboratory tests, and ancillary studies. Several reports have suggested that a patient history may provide most of the information for diagnosis in most patients (1 4); however, relatively little information is available in the medical literature concerning possible differences in the importance of each of the 5 encounter 1 Isabel Castrejón, MD, Lauren McCollum, BA, MA, Theodore Pincus, MD: New York University School of Medicine and New York University Hospital for Joint Diseases, New York; 2 Mine Durusu Tanriover, MD: Hacettepe University, Ankara, Turkey. Address correspondence to Theodore Pincus, MD, Division of Rheumatology, New York University Hospital for Joint Diseases, 301 East 17th Street, Room 1608, New York, NY tedpincus@gmail.com. Submitted for publication November 11, 2011; accepted in revised form February 15, components in the diagnosis and management of specific diseases. A patient history and physical examination may be regarded as clinician-intensive components of the clinical encounter, based on a requirement for the clinician to acquire the information in the examination room. By contrast, laboratory tests and ancillary studies may be regarded as non clinician-intensive components, collected and reimbursed outside of the examination room. Differences in the importance of clinician-intensive versus non clinician-intensive activities in (most) patients with different diagnoses might be considered in rational allocation of time and resources for scheduling, reimbursement, and general planning for optimal care. We surveyed physicians for their estimates of the relative importance of the 5 clinical encounter components in the diagnosis and management of 8 diseases: congestive heart failure (CHF), diabetes mellitus, hypercholesterolemia, hypertension, lymphoma, pulmonary fibrosis, rheumatoid arthritis (RA), and ulcerative colitis. Among these 1250

2 Impact of History and Physical Examination on Care of RA Patients 1251 Significance & Innovations Clinical encounters for the diagnosis and management of rheumatoid arthritis involve greater importance of information from a patient history and physical examination than for many other diseases, in which vital signs, laboratory tests, and ancillary studies are more important for diagnosis and management. A patient history and physical examination may be regarded as clinician-intensive components of a patient encounter, based on a requirement that the clinician acquire the information in the examination room, in contrast to non clinician-intensive laboratory tests and ancillary studies collected outside of the examination room. The findings support evidence that the care of patients with rheumatic diseases involves a higher burden for doctors than the care of patients with many other diseases. These observations appear to support the political positions of the American College of Rheumatology over many years, suggesting that rheumatologists may deserve greater reimbursement. 8 diseases, patient history and physical examination were estimated as most important by 50% of rheumatologists for only RA, and by 50% of nonrheumatologists for only RA and CHF, as presented in this report. Materials and methods Survey. The survey was conducted between January 7, 2010 and March 15, 2010 using the internet program SurveyMonkey. Physicians were queried to estimate the approximate percentage that each of 5 components vital signs, patient history, physical examination, laboratory tests, and ancillary studies contributes to the diagnosis or management of 8 diseases: CHF, diabetes mellitus, hypercholesterolemia, hypertension, lymphoma, pulmonary fibrosis, RA, and ulcerative colitis. The 8 diseases were selected to include the 2 most common diseases seen in internal medicine, hypertension and hypercholesterolemia) (5), and 6 diseases from 6 major disease categories: cardiovascular, neoplastic, musculoskeletal, gastrointestinal, pulmonary, and endocrine. The response options were 0 20%, 21 40%, 41 60%, 61 80%, or %. Two separate, identical drop-down menus were presented, the first for diagnosis and the second for management. This format was reported as the most user friendly by participants among several pilot formats, including 1 that queried an exact percentage for each component for a total of 100%. No honorarium was offered. Survey dissemination and completion. s with a link to the survey were sent to 7,265 US physicians, including 3,542 rheumatologists identified as members of the American College of Rheumatology and 3,723 family practitioners identified on the internet as affiliated with family practice training programs. The source of the survey was not identified as a rheumatologist to minimize possible bias in estimates concerning RA. Overall, 365 health professionals responded ( 5%). Analysis of responses. The 365 responses were downloaded to a Microsoft Excel spreadsheet. Fifty-two responses were excluded according to prespecified criteria: responses by a nonphysician, or not allowing a plausible comparison of the 5 clinical encounter components (after responses were recoded to the midpoint of each range, i.e., 10%, 30%, 50%, 70%, 90%), with sums of 350% in 6 diseases, 450% for 3 diseases, or omission of 3 diseases entirely over the 2 matrices. The 313 remaining responses were analyzed using Stata 12.0 for Windows (StataCorp) with several strategies, all yielding similar results. This study presents the proportions of rheumatologists and nonrheumatologists who estimated each component as the most important (or tied for the most important) in the diagnosis or management of each disease. Chi-square and Fischer s exact tests were performed to compare each of the 5 components for each diagnosis with one another; an adjusted P value of less than or less than , based on a P value less than 0.05 adjusted for 40 or 80 comparisons, respectively (6), was designated as statistically significant. Ethical approval. This survey study was reviewed prior to its performance by the Institutional Review Board (IRB) of New York University School of Medicine, which determined that the survey and study were exempt from a requirement of IRB approval. Results Responses of all physicians. One clinical encounter component was estimated as most important by significantly more physicians for the diagnosis and management of 5 of the 8 diseases (P , adjusted for 40 comparisons) (Table 1). More than 90% of the respondents estimated a single component as the most important in 3 diseases: vital signs for hypertension (97% for diagnosis and 96% for management) and laboratory tests for diabetes mellitus (96% for diagnosis and 95% for management) and hypercholesterolemia (99% for diagnosis and 97% for management) (Table 1 and Figure 1). Ancillary studies were estimated as most important by 90% for the diagnosis of pulmonary fibrosis (93%) and ulcerative colitis (92%), by 70% for the diagnosis and management of lymphoma (72% and 74%, respectively), and by 50% for the diagnosis of CHF (61%), the management of pulmonary fibrosis (69%), and the management of ulcerative colitis (58%) (Table 1). Only 5 comparisons (for the diagnosis and management of CHF and RA and the management of ulcerative colitis) included 2 components that were estimated to differ significantly from the other components (Table 1). Patient history was estimated as most important by 50% for the diagnosis and management of RA (64% and 74%, respectively) and the management of CHF (58%),

3 1252 Castrejón et al Table 1. Proportions of 313 US physicians who estimated each of 5 clinical encounter components as most important in the diagnosis and management of 8 diseases* Vital signs Patient history Physical examination Laboratory tests Ancillary studies P P Congestive heart failure Diagnosis Management Diabetes mellitus Diagnosis Management Hypercholesterolemia Diagnosis Management Hypertension Diagnosis Management Lymphoma Diagnosis Management Pulmonary fibrosis Diagnosis Management Rheumatoid arthritis Diagnosis Management Ulcerative colitis Diagnosis Management * Values are the percentage. Totals may exceed 100% because of ties. Comparisons were by chi-square test; P was significant (P 0.05, adjusted for 40 comparisons). Highest versus others. Highest versus others, except second highest. pulmonary fibrosis (51%), and ulcerative colitis (58%). Physical examination was estimated as most important by 50% for the diagnosis and management of RA (71% and 65%, respectively) and the diagnosis and management of CHF (65% and 62%, respectively) (Table 1). Patient history and physical examination were estimated as most important by 46% of all respondents for only 2 of the 8 diseases, RA and CHF. In general, the same component was estimated as most important for both the diagnosis and management of each disease (Table 1 and Figure 1); 30 of 40 comparisons for diagnosis and management were within a 10% range for each component, and 36 of 40 comparisons were within a 20% range. The only 4 comparisons that differed by 20% were higher estimated importance of ancillary studies in the diagnosis (versus management) of pulmonary fibrosis and ulcerative colitis, and higher estimated importance of patient history in the management (versus diagnosis) of these 2 diseases. Rheumatologists compared to nonrheumatologists. The estimates of rheumatologists and nonrheumatologists concerning the most important clinical encounter component were in the same range; 57 of 80 comparisons differed by 10%, 68 of 80 by 20%, and all 80 by 31% (Table 2). Significant differences (P adjusted for multiple comparisons) were seen for 10 comparisons. Patient history was estimated as most important for the management of CHF by 68% of nonrheumatologists versus 48% of rheumatologists. Physical examination was estimated as most important for the diagnosis and management of RA by 86% and 80% of rheumatologists, respectively, compared to 55% and 50% of nonrheumatologists, respectively. Laboratory tests were estimated as most important for the diagnosis and management of lymphoma by 54% and 56% of nonrheumatologists, respectively, compared to 32% and 37% of rheumatologists, respectively, and for the diagnosis and management of RA by 42% and 26% of nonrheumatologists, respectively, compared to 16% and 10% of rheumatologists, respectively. Ancillary studies were estimated as most important for the management of CHF by 53% of rheumatologists compared to 31% of nonrheumatologists, and were estimated as most important for the diagnosis and management of lymphoma by 84% and 79% of rheumatologists, respectively, compared to 60% and 68% of nonrheumatologists, respectively. Other differences were not statistically significant in adjusted analyses, although some differences likely would be significant with a larger sample. Nonetheless, most estimates were in a similar range. Discussion Substantial differences were seen in the physicians estimates of the most important components of the clinical encounter for the diagnosis and management of 8 diseases.

4 Impact of History and Physical Examination on Care of RA Patients 1253 Figure 1. The most important sources of information for diagnosis (A) and management (B) of 8 chronic diseases. VS vital signs; HX patient history; PE physical examination; LAB laboratory tests; ANC ancillary studies. These differences appear to have face validity, despite a response rate of only 5%, although few formal studies that sought to estimate the importance of different components of the clinical encounter in different diseases have been previously reported. Previous reports, published between 1975 and 1993, have suggested that a patient history provides most of the information for the diagnosis in most patients (1 4). Patient history certainly contributes to the choices of laboratory tests and ancillary studies in most diagnostic evaluations, and would likely be estimated as more important in the diagnosis of many common diseases not included in this study, such as angina, asthma, and others. Nonetheless, contemporary medical activities include the care of many asymptomatic individuals with chronic conditions such as hypertension and hyperlipidemia, in whom a patient history is required primarily to recognize the possible complications of these conditions and adverse effects of medications, but usually not to treat the primary disease. The growing prominence of laboratory tests and ancillary studies in many diseases at this time may render the traditional medical history and physical examination less important in the diagnosis and management of diseases than in years past. The patient history and physical examination were estimated as having high importance for RA by 50% of both rheumatologists and nonrheumatologists, and for CHF by 50% of nonrheumatologists. The patient history was estimated as most important in the management of ulcerative colitis by 50% of both groups, and the management of pulmonary fibrosis by 50% of nonrheumatologists. Otherwise, the patient history and physical examination were estimated as most important by fewer than 50% of the respondents for the 6 diseases other than RA and CHF, generally far fewer than 50%. Laboratory tests and ancillary studies dominate the clinical information sought by most physicians and patients from a medical encounter at this time. This perspective appears appropriate for certain diseases such as diabetes mellitus and hypercholesterolemia, but may be poorly informative for clinical decisions in many other diseases. For example, many physicians order extensive laboratory tests for patients with suspected RA, which often may not be helpful. Only 55 65% of RA patients have abnormal values for erythrocyte sedimentation rate and C-reactive protein (7), and only 70 75% have positive tests for rheumatoid factor and anti citrullinated peptide antibodies (8). Furthermore, false-positive tests are seen in 5% of normal individuals, 10 times more common than the prevalence of RA of 0.5% (8). Perhaps greater awareness of the data presented here may reduce laboratory testing in certain diseases to improve cost-effectiveness without compromising quality of care. Patient history and physical examination may be regarded as clinician-intensive activities within a clinical encounter, since the clinician collects this information in

5 1254 Castrejón et al Table 2. Proportions of 154 rheumatologists and 159 nonrheumatologists who estimated each of 5 clinical encounter components as most important in the diagnosis and management of 8 diseases* Vital signs Patient history Physical examination Laboratory tests Ancillary studies Rh Non-Rh Rh Non-Rh Rh Non-Rh Rh Non-Rh Rh Non-Rh Congestive heart failure Diagnosis Management Diabetes mellitus Diagnosis Management Hypercholesterolemia Diagnosis Management Hypertension Diagnosis Management Lymphoma Diagnosis Management Pulmonary fibrosis Diagnosis Management Rheumatoid arthritis Diagnosis Management Ulcerative colitis Diagnosis Management * Values are the percentage. Totals may exceed 100% due to ties. P for 70 of 80 comparisons (P 0.05, adjusted for 80 comparisons). Rh rheumatologist. P for nonrheumatologists versus rheumatologists, adjusted for 80 comparisons. the examination room. By contrast, laboratory tests and ancillary studies are non clinician intensive, generally collected outside of the examination room and reimbursed independently. Patients whose diseases require greater clinician-intensive information might require longer and more complex visits than patients with diseases in which decisions are based largely on non clinician-intensive information. Rheumatologists estimated physical examination as more important in RA than nonrheumatologists, who estimated patient history and laboratory tests as more important (Table 2). This pattern may apply to other specialists in the care of patients with diseases within their specialties (e.g., CHF and pulmonary fibrosis). Further research concerning this matter would appear of interest, but it is beyond the scope of this study. Nonetheless, 50% of both rheumatologists and nonrheumatologists estimated patient history and physical examination as having high importance for RA. Many limitations are seen to this study. First, only 365 physicians responded to the survey ( 5%); however, this response rate may be seen in survey research. Furthermore, the face validity and consistency of responses suggest that the data likely reflected clinical practice accurately. Second, the queries were overly simplified, without attention to possible differences in individual patients and practices that may affect the estimated importance of assessment components in clinical decisions. For example, increased use of ultrasound and nonphysician rheumatology health professionals in the diagnosis and management of RA might have altered the estimates of some clinicians. Third, no attempt was made to validate the physicians opinions through observations in actual care (1 4,9); however, information concerning the importance to physicians of components of a clinical encounter must necessarily be based on their estimates (10). Fourth, many small differences between subgroups were not addressed, as the focus of this report was large differences that have not been reported previously. Fifth, all physicians were regarded as identical, ignoring possible differences according to age, sex, experience levels, and geographic areas, among others, although no significant trends were seen according to respondent characteristics in this relatively small sample (data not shown). Sixth, all patients were regarded as identical, although certain patients, particularly disadvantaged individuals (11), may require considerable clinicianintensive counseling, which may render an encounter of a patient with hypertension or diabetes mellitus as complex as a visit of a patient with other diseases. The magnitude of estimated differences of the most important encounter components in the diagnosis and management of most patients with different diseases suggests possible new approaches to address some limitations of current evaluation and management guidelines for medi-

6 Impact of History and Physical Examination on Care of RA Patients 1255 cal visits (12). Further surveys of additional diseases, and studies to record the actual time spent by clinicians in reviewing a patient history and performing a physical examination in patients with different diseases, could further validate the physicians estimates in this study; however, such investigations are beyond the scope of the present study. Further research concerning how different assessment components are used in the diseases studied here, additional diseases, by different types of physicians, and in different types of patients might lead to better strategies for cost containment and reimbursement, more rational allocation of time and resources in the care of patients with chronic diseases, and improved patient outcomes. AUTHOR CONTRIBUTIONS All authors were involved in drafting the article or revising it critically for important intellectual content, and all authors approved the final version to be published. Dr. Pincus had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study conception and design. Castrejón, McCollum, Pincus. Acquisition of data. McCollum, Durusu Tanriover. Analysis and interpretation of data. Castrejón, McCollum, Pincus. REFERENCES 1. Hampton JR, Harrison MJ, Mitchell JR, Prichard JS, Seymour C. Relative contributions of history-taking, physical examination, and laboratory investigation to diagnosis and management of medical outpatients. Br Med J 1975;2: Sandler G. The importance of the history in the medical clinic and the cost of unnecessary tests. Am Heart J 1980;100: Peterson MC, Holbrook JH, Hales DV, Smith NL, Staker LV. Contributions of the history, physical examination, and laboratory investigation in marking medical diagnoses. West J Med 1992;56: Pryor DB, Shaw L, McCants CB, Lee KL, Mark DB, Harrell FE Jr, et al. Value of the history and physical in identifying patients at increased risk for coronary artery disease. Ann Intern Med 1993;118: Wilper AP, Woolhandler S, Lasser KE, McCormick D, Bor DH, Himmelstein DU. A national study of chronic disease prevalence and access to care in uninsured U.S. adults. Ann Intern Med 2008;149: Cupples LA, Heeren T, Schatzkin A, Colton T. Multiple testing of hypotheses in comparing two groups. Ann Intern Med 1984;100: Sokka T, Pincus T. Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35%-45% of patients with rheumatoid arthritis seen between 1980 and 2004: analyses from Finland and the United States. J Rheumatol 2009;36: Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S, et al. Meta-analysis: diagnostic accuracy of anticyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 2007;146: Reilly BM. Physical examination in the care of medical inpatients: an observational study. Lancet 2003;362: Laine C, Davidoff F, Lewis CE, Nelson EC, Nelson E, Kessler RC, et al. Important elements of outpatient care: a comparison of patients and physicians opinions. Ann Intern Med 1996; 125: Pincus T, Esther R, De Walt DA, Callahan LF. Social conditions and self-management are more powerful determinants of health than access to care. Ann Intern Med 1998;129: Kassirer JP, Angell M. Evaluation and management guidelines: fatally flawed [editorial]. N Engl J Med 1998;339:

Dr(Lt General) Ved Chaturvedi

Dr(Lt General) Ved Chaturvedi Dr(Lt General) Ved Chaturvedi MD.DM Sr Rheumatologist,Sir Ganga Ram Hospital New Delhi President Delhi Rheumatology Association,ex president Indian Rheumatology association ex HOD Rheumatology Research

More information

Pragmatic and Scientific Advantages of MDHAQ/ RAPID3 Completion by All Patients at All Visits in Routine Clinical Care

Pragmatic and Scientific Advantages of MDHAQ/ RAPID3 Completion by All Patients at All Visits in Routine Clinical Care S30 Pragmatic and Scientific Advantages of MDHAQ/ RAPID3 Completion by All Patients at All Visits in Routine Clinical Care Theodore Pincus, M.D., Yusuf Yazici, M.D., and Isabel Castrejón, M.D. Abstract

More information

A RheuMetric physician checklist to quantitate levels of inflammation, damage and distress on 0 10 visual analogue scales

A RheuMetric physician checklist to quantitate levels of inflammation, damage and distress on 0 10 visual analogue scales A RheuMetric physician checklist to quantitate levels of inflammation, damage and distress on 0 10 visual analogue scales I. Castrejón, J.R. Chua, T. Pincus Division of Rheumatology, Rush University Medical

More information

RHEUMATOLOGY TRAINING AT INTERNAL MEDICINE AND FAMILY PRACTICE RESIDENCY PROGRAMS

RHEUMATOLOGY TRAINING AT INTERNAL MEDICINE AND FAMILY PRACTICE RESIDENCY PROGRAMS 47 1 SPECIAL ARTICLE RHEUMATOLOGY TRAINING AT INTERNAL MEDICINE AND FAMILY PRACTICE RESIDENCY PROGRAMS DON L. GOLDENBERG, RAPHAEL J. DEHORATIUS, STEPHEN R. KAPLAN, JOHN MASON, ROBERT MEENAN, SUSAN G. PERLMAN,

More information

Overview of the Synthetic Derivative

Overview of the Synthetic Derivative Overview of the Synthetic Derivative April 22, 2009 Melissa Basford, MBA Program Manager, BioVU and Synthetic Derivative What is BioVU? A biobank intended to support a broad view of biology Currently contains

More information

Best Practices in Managing Patients with Rheumatoid Arthritis. University of Rochester. Adding Patient Reported Outcome Measures

Best Practices in Managing Patients with Rheumatoid Arthritis. University of Rochester. Adding Patient Reported Outcome Measures Best Practices in Managing Patients with Rheumatoid Arthritis Adding Patient Reported Outcome Measures Organizational Profile Strong Memorial Hospital is a large tertiary care center located in Rochester,

More information

Introduction to the Partners Biobank Portal. December 2016

Introduction to the Partners Biobank Portal. December 2016 Introduction to the Partners Biobank Portal December 2016 Agenda About the Partners Biobank About the Biobank Portal Data Types in the Biobank Sample types DNA. Plasma and Serum Consent Genomic Data Health

More information

Assessing Remission in Rheumatoid Arthritis on the Basis of Patient Reported Outcomes

Assessing Remission in Rheumatoid Arthritis on the Basis of Patient Reported Outcomes 136 Bulletin of the Hospital for Joint Diseases 2014;72(2):136-41 Assessing Remission in Rheumatoid Arthritis on the Basis of Patient Reported Outcomes Advantages of Using RAPID3/MDHAQ in Routine Care

More information

AMERICAN COLLEGE OF RHEUMATOLOGY POSITION STATEMENT. Committee on Rheumatologic Care

AMERICAN COLLEGE OF RHEUMATOLOGY POSITION STATEMENT. Committee on Rheumatologic Care AMERICAN COLLEGE OF RHEUMATOLOGY POSITION STATEMENT SUBJECT: PRESENTED BY: FOR DISTRIBUTION TO: Bone Mineral Density Measurement and the Role of Rheumatologists in the Management of Osteoporosis Committee

More information

Alternative Payment Model for ACR members

Alternative Payment Model for ACR members Vision - Opportunity - Value Alternative Payment Model for ACR members Kwas Huston Ed Herzig Doug White The APM work group Development of the Rheumatoid Arthritis APM Opportunity to develop a new model

More information

Financial Disclosure. Learning Objectives. Evaluation of Chemotherapy in Last 2 Weeks of Life: CAMC Patterns of Care

Financial Disclosure. Learning Objectives. Evaluation of Chemotherapy in Last 2 Weeks of Life: CAMC Patterns of Care Evaluation of Chemotherapy in Last 2 Weeks of Life: CAMC Patterns of Care Steven J. Jubelirer, MD Clinical Professor Medicine WVU Charleston Division Senior Research Scientist CAMC Research Institute Charleston

More information

BRIEF REPORTS. Effectiveness of a Smartphone App for Guiding Antidepressant Drug Selection Colin Man; Cathina Nguyen; Steven Lin, MD

BRIEF REPORTS. Effectiveness of a Smartphone App for Guiding Antidepressant Drug Selection Colin Man; Cathina Nguyen; Steven Lin, MD Effectiveness of a Smartphone App for Guiding Antidepressant Drug Selection Colin Man; Cathina Nguyen; Steven Lin, MD BACKGROUND AND OBJECTIVES: Major depression is a prevalent chronic disease in the United

More information

Designing an Electronic Medical Record-based Clinical Decision Support Tool to Improve CVD Screening in Rheumatoid Arthritis Patients

Designing an Electronic Medical Record-based Clinical Decision Support Tool to Improve CVD Screening in Rheumatoid Arthritis Patients Designing an Electronic Medical Record-based Clinical Decision Support Tool to Improve CVD Screening in Rheumatoid Arthritis Patients Provided and Certified By Grant Award # 045604 Report Date: March 29,

More information

Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism

Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism Agency for Healthcare Research and Quality Evidence Report/Technology Assessment Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism Summary Number 68 Overview Venous thromboembolism

More information

Abatacept (Orencia) for active rheumatoid arthritis. August 2009

Abatacept (Orencia) for active rheumatoid arthritis. August 2009 Abatacept (Orencia) for active rheumatoid arthritis August 2009 This technology summary is based on information available at the time of research and a limited literature search. It is not intended to

More information

SYNOPSIS. Clinical Study Report IM Double-blind Period

SYNOPSIS. Clinical Study Report IM Double-blind Period Name of Sponsor/Company: Bristol-Myers Squibb Name of Finished Product: Abatacept () Name of Active Ingredient: Abatacept () Individual Study Table Referring to the Dossier SYNOPSIS (For National Authority

More information

Research Article. Disease management in pediatric lupus: could it pose a burden?

Research Article. Disease management in pediatric lupus: could it pose a burden? Disease management in pediatric lupus: could it pose a burden? Aims: To identify disease management-related activities that could pose a burden to patients with systemic lupus erythematosus (SLE) and their

More information

Survey on Chronic Respiratory Diseases at the PrimaryHealth Care Level

Survey on Chronic Respiratory Diseases at the PrimaryHealth Care Level Survey on Chronic Respiratory Diseases at the PrimaryHealth Care Level Nikolai Khaltaev MD, PhD GARD General Meeting Istanbul, Turkey, 30-31 May 2008 Burden of major respiratory diseases Respiratory diseases

More information

A 3-page standard protocol to evaluate rheumatoid arthritis (SPERA): Efficient capture of essential data for clinical trials and observational studies

A 3-page standard protocol to evaluate rheumatoid arthritis (SPERA): Efficient capture of essential data for clinical trials and observational studies A 3-page standard protocol to evaluate rheumatoid arthritis (SPERA): Efficient capture of essential data for clinical trials and observational studies T. Pincus Division of Rheumatology and Immunology,

More information

Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events

Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events Diabetes Care Publish Ahead of Print, published online May 28, 2008 Chronotropic response in patients with diabetes Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts

More information

PQRS 2015Applicable Measure Group Codes ICD-9 and ICD-10 diagnosis codes and CPT encounter and surgical codes

PQRS 2015Applicable Measure Group Codes ICD-9 and ICD-10 diagnosis codes and CPT encounter and surgical codes PQRS 2015Applicable Measure Group Codes ICD-9 and and CPT encounter and surgical codes Acute Otisis Externa (AOE) Measures Group Page 1 Asthma Measures Group Page 2 Coronary Artery Bypass Graft (CABG)

More information

Electronic MDHAQ / T. Pincus

Electronic MDHAQ / T. Pincus Electronic multidimensional health assessment questionnaire (emdhaq): past, present and future of a proposed single data management system for clinical care, research, quality improvement, and monitoring

More information

Unmanaged Behavioral Health Puts Your Company At Risk. Presented by: Dr. Sam Mayhugh Integrated Behavioral Health

Unmanaged Behavioral Health Puts Your Company At Risk. Presented by: Dr. Sam Mayhugh Integrated Behavioral Health Unmanaged Behavioral Health Puts Your Company At Risk Presented by: Dr. Sam Mayhugh Integrated Behavioral Health Behavioral Health Management Webinar Overview History of BH management Prevalence of behavioral

More information

Tackling Depression: The State of Tennessee s Be Well At Work Program Approach

Tackling Depression: The State of Tennessee s Be Well At Work Program Approach Tackling Depression: The State of Tennessee s Be Well At Work Program Approach Director of the Program on Health, Work and Productivity, Tufts Medical Center John Allen, LCSW, CEAP, SPHR Director of Behavioral

More information

Medical care at this time is based largely on a

Medical care at this time is based largely on a Bulletin of the NYU Hospital for Joint Diseases 2007;65(Suppl 1):S29-36 S29 Patient Questionnaires and Formal Education as More Significant Prognostic Markers than Radiographs or Laboratory Tests for Rheumatoid

More information

TREAT-TO-TARGET IN RHEUMATOID ARTHRITIS

TREAT-TO-TARGET IN RHEUMATOID ARTHRITIS TREAT-TO-TARGET IN RHEUMATOID ARTHRITIS To receive up to 10 CME credits for this activity, complete the evaluation, attestation and post-test answer sheet (minimum passing grade of 70%) and return all

More information

(minutes for web publishing)

(minutes for web publishing) Rheumatology Subcommittee of the Pharmacology and Therapeutics Advisory Committee (PTAC) Meeting held on 17 October 2017 (minutes for web publishing) Rheumatology Subcommittee minutes are published in

More information

Dipstick Urinalysis as a Test for Microhematuria and Occult Bladder Cancer

Dipstick Urinalysis as a Test for Microhematuria and Occult Bladder Cancer Bladder Cancer 3 (2017) 45 49 DOI 10.3233/BLC-160068 IOS Press Research Report 45 Dipstick Urinalysis as a Test for Microhematuria and Occult Bladder Cancer Richard S. Matulewicz a,b,, John Oliver DeLancey

More information

Pfizer Independent Grants for Learning & Change Request for Proposals (RFP) Rheumatoid Arthritis Mono- and Combination DMARD Therapy in RA Patients

Pfizer Independent Grants for Learning & Change Request for Proposals (RFP) Rheumatoid Arthritis Mono- and Combination DMARD Therapy in RA Patients Pfizer Independent Grants for Learning & Change Request for Proposals (RFP) Rheumatoid Arthritis Mono- and Combination DMARD Therapy in RA Patients I. Background The mission of Pfizer Independent Grants

More information

Cambia Palliative Care Metrics: Where are we and where are we going?

Cambia Palliative Care Metrics: Where are we and where are we going? Cambia Palliative Care Metrics: Where are we and where are we going? J. Randall Curtis, MD, MPH Director, Cambia Palliative Care Center of Excellence www.uwpalliativecarecenter.com Overview of System-Wide

More information

1.0 Abstract. Title. Keywords. Rationale and Background

1.0 Abstract. Title. Keywords. Rationale and Background 1.0 Abstract Title A Prospective, Multi-Center Study in Rheumatoid Arthritis Patients on Adalimumab to Evaluate its Effect on Synovitis Using Ultrasonography in an Egyptian Population Keywords Synovitis

More information

Evidence-Based Review Process to Link Dietary Factors with Chronic Disease Case Study: Cardiovascular Disease and n- 3 Fatty Acids

Evidence-Based Review Process to Link Dietary Factors with Chronic Disease Case Study: Cardiovascular Disease and n- 3 Fatty Acids Evidence-Based Review Process to Link Dietary Factors with Chronic Disease Case Study: Cardiovascular Disease and n- 3 Fatty Acids Alice H. Lichtenstein, D.Sc. Gershoff Professor of Nutrition Science and

More information

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARD FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based)

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARD FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based) Last Updated: Version 4.3 NQF-ENDORSED VOLUNTARY CONSENSUS STANDARD FOR HOSPITAL CARE Measure Information Form Collected For: CMS Outcome Measures (Claims Based) Measure Set: CMS Readmission Measures Set

More information

Aspartate Aminotransferase Testing in Community-Based Laboratories: An Expert Consultation

Aspartate Aminotransferase Testing in Community-Based Laboratories: An Expert Consultation Aspartate Aminotransferase Testing in Community-Based Laboratories: An Expert Consultation B McCurdy June 2013 Aspartate Aminotransferase Testing in Community-Based Laboratories. June 2013; pp. 1 11. Suggested

More information

Prevalence of chronic diseases in the population covered by medical aid schemes in South Africa

Prevalence of chronic diseases in the population covered by medical aid schemes in South Africa Prevalence of chronic diseases in the population covered by medical aid schemes in South Africa Research and Monitoring Unit June 2014 Chairperson: Prof. Y Veriava Chief Executive & Registrar: Dr M Gantsho

More information

Cost-effectiveness analysis of biological treatments for rheumatoid arthritis Chiou C F, Choi J, Reyes C M

Cost-effectiveness analysis of biological treatments for rheumatoid arthritis Chiou C F, Choi J, Reyes C M Cost-effectiveness analysis of biological treatments for rheumatoid arthritis Chiou C F, Choi J, Reyes C M Record Status This is a critical abstract of an economic evaluation that meets the criteria for

More information

SUPPLEMENTAL MATERIAL. Supplemental Methods. Duke CAD Index

SUPPLEMENTAL MATERIAL. Supplemental Methods. Duke CAD Index SUPPLEMENTAL MATERIAL Supplemental Methods Duke CAD Index The Duke CAD index, originally developed by David F. Kong, is an angiographic score that hierarchically assigns prognostic weights (0-100) based

More information

The Prognostic Importance of Comorbidity for Mortality in Patients With Stable Coronary Artery Disease

The Prognostic Importance of Comorbidity for Mortality in Patients With Stable Coronary Artery Disease Journal of the American College of Cardiology Vol. 43, No. 4, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2003.10.031

More information

Understanding Rheumatoid Arthritis

Understanding Rheumatoid Arthritis Understanding Rheumatoid Arthritis Understanding Rheumatoid Arthritis What Is Rheumatoid Arthritis? 1,2 Rheumatoid arthritis (RA) is a chronic autoimmune disease. It causes joints to swell and can result

More information

NORTH CAROLINA STATE HEALTH PLAN FOR TEACHERS AND STATE EMPLOYEES

NORTH CAROLINA STATE HEALTH PLAN FOR TEACHERS AND STATE EMPLOYEES NORTH CAROLINA STATE HEALTH PLAN FOR TEACHERS AND STATE EMPLOYEES Using Clinical Risk Groups to Focus Board Strategic Initiatives July 26, 2013 Copyright 2013 by The Segal Group, Inc., parent of The Segal

More information

1.0 Abstract. Title P13-562

1.0 Abstract. Title P13-562 1.0 Abstract Title P13-562 Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn s Disease and Ulcerative Colitis patients`adherence attitudes to maintenance

More information

Declines of tender and swollen joint counts between 1985 and 2001 in patients. with rheumatoid arthritis seen in standard care:

Declines of tender and swollen joint counts between 1985 and 2001 in patients. with rheumatoid arthritis seen in standard care: ARD Online First, published on December 8, 2005 as 10.1136/ard.2005.044131 1 2 3 1 Declines of tender and swollen joint counts between 1985 and 2001 in patients with rheumatoid arthritis seen in standard

More information

April 2o14. The 2013 Drug Trend Report Highlights

April 2o14. The 2013 Drug Trend Report Highlights April 2o14 The 2013 Drug Trend Report Highlights Express Scripts Reports Lowest Specialty Drug Trend Since 2007 In 2013, spending on prescription drugs increased 5.4% after several years of slower-paced

More information

NCCP Chemotherapy Regimen. Brentuximab vedotin Monotherapy

NCCP Chemotherapy Regimen. Brentuximab vedotin Monotherapy Brentuximab INDICATIONS FOR USE: INDICATION ICD10 Regimen Code *Reimbursement Status Treatment of adult patients with relapsed or refractory CD30+ Hodgkin lymphoma (HL): Following autologous stem cell

More information

Multi-Specialty Quality Measure Information Sheet 2017

Multi-Specialty Quality Measure Information Sheet 2017 Prevention and Screening Adolescent Preventive Care Measures (APC) The percentage of adolescents 12-17 years of age who had at least one outpatient visit with a PCP or OB/ GYN practitioner during the measurement

More information

II. Requirements Date RFP Issued: 07/11/2013 Use of Patient-Reported Outcome Measures in Management of Rheumatoid Arthritis (RA) I.

II. Requirements Date RFP Issued: 07/11/2013 Use of Patient-Reported Outcome Measures in Management of Rheumatoid Arthritis (RA) I. Pfizer Independent Grants for Learning & Change Request for Proposals (RFP) Rheumatoid Arthritis Patient-Reported Outcome Measures in Management of Rheumatoid Arthritis I. Background The mission of Pfizer

More information

Primary Health Care Initiatives (PHCI) Project Contract No. 278-C Abt. Associates Inc.

Primary Health Care Initiatives (PHCI) Project Contract No. 278-C Abt. Associates Inc. Primary Health Care Initiatives (PHCI) Project Contract No. 278-C-00-99-00059-00 Abt. Associates Inc. BASIC EPIDEMIOLOGY LEARNING OBJECTIVES Define epidemiology and its scope and importance Know some of

More information

NCCP Chemotherapy Regimen. Brentuximab vedotin Monotherapy

NCCP Chemotherapy Regimen. Brentuximab vedotin Monotherapy INDICATIONS FOR USE: INDICATION Brentuximab Treatment of adult patients with relapsed or refractory CD30+ Hodgkin lymphoma (HL): Following autologous stem cell transplant (ASCT) or Following at least two

More information

The NICE chest pain guideline 1 year on. Jane S Skinner Consultant Community Cardiologist The Newcastle upon Tyne Hospitals NHS Foundation Trust

The NICE chest pain guideline 1 year on. Jane S Skinner Consultant Community Cardiologist The Newcastle upon Tyne Hospitals NHS Foundation Trust The NICE chest pain guideline 1 year on Jane S Skinner Consultant Community Cardiologist The Newcastle upon Tyne Hospitals NHS Foundation Trust The Society for Acute Medicine, 5 th International Conference,

More information

Osteoporosis: Turning up the volume on a silent disease? 2006 Programs. Program Chair David Dempster, PhD

Osteoporosis: Turning up the volume on a silent disease? 2006 Programs. Program Chair David Dempster, PhD 8030 Peters Road, D105 Plantation, Florida 33324 (954) 723-0057 Phone (954) 723-0353 Fax email: info@naceonline.com Osteoporosis: Turning up the volume on a silent disease? 2006 Programs Program Chair

More information

PROSPERO International prospective register of systematic reviews

PROSPERO International prospective register of systematic reviews PROSPERO International prospective register of systematic reviews What is the application of ultrasound imaging in primary care for musculoskeletal disorders? Mark Karaczun, Toby Smith, Robert Fleetcroft,

More information

TENNCARE Bundled Payment Initiative: Description of Bundle Risk Adjustment for Wave 4 Episodes

TENNCARE Bundled Payment Initiative: Description of Bundle Risk Adjustment for Wave 4 Episodes TENNCARE Bundled Payment Initiative: Description of Bundle Risk Adjustment for Wave 4 Episodes Attention deficit hyperactivity disorder (ADHD); Opposition defiance disorder (ODD); Coronary artery bypass

More information

T. Pincus 1, B. Richardson 2, V. Strand 3, M.J. Bergman 4

T. Pincus 1, B. Richardson 2, V. Strand 3, M.J. Bergman 4 Relative efficiencies of the 7 rheumatoid arthritis Core Data Set measures to distinguish active from control treatments in 9 comparisons from clinical trials of 5 agents T. Pincus 1, B. Richardson 2,

More information

HIV testing technologies

HIV testing technologies HIV testing technologies HIV testing technologies are used to determine if a person has HIV. Several types of HIV testing technologies are used in Canada. These tests differ in several ways, including

More information

Effect of methotrexate on serum levels of anti-ccp antibodies and different classes of rheumatoid factors in rheumatoid arthritis patients

Effect of methotrexate on serum levels of anti-ccp antibodies and different classes of rheumatoid factors in rheumatoid arthritis patients Clinical immunology DOI: 10.5114/ceji.2012.30802 Effect of methotrexate on serum levels of anti-ccp antibodies and different classes of rheumatoid factors in rheumatoid arthritis patients JERZY ŒWIERKOT,

More information

ECOND ANNUAL INTERNAL MEDICINE REVIEW October Ramee Grand Hotel 26 CME CREDITS. Renowned Speakers. Days Review Program ACCREDITED BY NHRA FOR

ECOND ANNUAL INTERNAL MEDICINE REVIEW October Ramee Grand Hotel 26 CME CREDITS. Renowned Speakers. Days Review Program ACCREDITED BY NHRA FOR ACCREDITED BY NHRA FOR 26 CME CREDITS ECOND ANNUAL INTERNAL MEDICINE REVIEW 4 12 Renowned Speakers Days Review Program Organizer: 2017 25-28 October Ramee Grand Hotel Manama, Kingdom www.mobilitybh.com

More information

RNHRD Rheumatology Services

RNHRD Rheumatology Services Dr Ellie Korendowych Consultant Rheumatologist & Clinical Lead for Rheumatology RNHRD Rheumatology Services Rheumatology Upper Borough Walls, Bath, BA1 1RL Our vision To advance excellence in clinical

More information

How are testing technologies used to diagnose HIV infection?

How are testing technologies used to diagnose HIV infection? HIV testing technologies are used to determine if a person has HIV. Several types of HIV testing technologies are used in Canada. These tests differ in several ways, including where the test is conducted,

More information

Horizon Scanning Technology Summary. Abatacept (Orencia) for juvenile idiopathic arthritis. National Horizon Scanning Centre.

Horizon Scanning Technology Summary. Abatacept (Orencia) for juvenile idiopathic arthritis. National Horizon Scanning Centre. Horizon Scanning Technology Summary National Horizon Scanning Centre Abatacept (Orencia) for juvenile idiopathic arthritis June 2007 This technology summary is based on information available at the time

More information

The Effect of Alcohol Prep Pads and Blood Drop Number On Capillary Blood Glucose Values

The Effect of Alcohol Prep Pads and Blood Drop Number On Capillary Blood Glucose Values University of New Hampshire University of New Hampshire Scholars' Repository Honors Theses and Capstones Student Scholarship Spring 2017 The Effect of Alcohol Prep Pads and Blood Drop Number On Capillary

More information

Understanding Hierarchical Condition Categories (HCC)

Understanding Hierarchical Condition Categories (HCC) Understanding Hierarchical Condition Categories (HCC) How hierarchical condition category coding will impact your practice and how you can use these codes to increase quality, improve the patient experience,

More information

An Analytical Review of the Pew Report Entitled, It Takes A Team and the Accompanying Productivity and Profit Calculator

An Analytical Review of the Pew Report Entitled, It Takes A Team and the Accompanying Productivity and Profit Calculator An Analytical Review of the Pew Report Entitled, It Takes A Team and the Accompanying Productivity and Profit Calculator The report, It Takes a Team, was released by the Pew Center on the States in December

More information

Impact of Chest Pain Protocol Targeting Intermediate Cardiac Risk Patients in an Observation Unit of an Academic Tertiary Care Center

Impact of Chest Pain Protocol Targeting Intermediate Cardiac Risk Patients in an Observation Unit of an Academic Tertiary Care Center Elmer ress Original Article J Clin Med Res. 2016;8(2):111-115 Impact of Chest Pain Protocol Targeting Intermediate Cardiac Risk Patients in an Observation Unit of an Academic Tertiary Care Center Tariq

More information

Clinical Policy: Etanercept (Enbrel) Reference Number: PA.CP.PHAR.250 Effective Date: 01/18 Last Review Date: 08/17 Line of Business: Medicaid

Clinical Policy: Etanercept (Enbrel) Reference Number: PA.CP.PHAR.250 Effective Date: 01/18 Last Review Date: 08/17 Line of Business: Medicaid Clinical Policy: (Enbrel) Reference Number: PA.CP.PHAR.250 Effective Date: 01/18 Last Review Date: 08/17 Line of Business: Medicaid Coding Implications Revision Log Description (Enbrel ) is tumor necrosis

More information

THE BATH ANKYLOSING SPONDYLITIS PATIENT GLOBAL SCORE (BAS-G)

THE BATH ANKYLOSING SPONDYLITIS PATIENT GLOBAL SCORE (BAS-G) British Journal of Rheumatology 1996;35:66-71 THE BATH ANKYLOSING SPONDYLITIS PATIENT GLOBAL SCORE (BAS-G) S. D. JONES, A. STEINER,* S. L. GARRETT and A. CALIN Royal National Hospital for Rheumatic Diseases,

More information

I nuovi criteri ACR/EULAR per la classificazione dell artrite reumatoide

I nuovi criteri ACR/EULAR per la classificazione dell artrite reumatoide I nuovi criteri ACR/EULAR per la classificazione dell artrite reumatoide Pierluigi Macchioni Struttura Complessa di Reumatologia, Ospedale di Reggio Emilia Topics 1987 ACR classification criteria for RA

More information

Interval Likelihood Ratios: Another Advantage for the Evidence-Based Diagnostician

Interval Likelihood Ratios: Another Advantage for the Evidence-Based Diagnostician EVIDENCE-BASED EMERGENCY MEDICINE/ SKILLS FOR EVIDENCE-BASED EMERGENCY CARE Interval Likelihood Ratios: Another Advantage for the Evidence-Based Diagnostician Michael D. Brown, MD Mathew J. Reeves, PhD

More information

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Quality ID #177: Rheumatoid Arthritis (RA): Periodic Assessment of Disease Activity National Quality Strategy Domain: Effective Clinical Care Measure Meaningful Measure Area: Management of Chronic Conditions

More information

Description of Study Protocol. Data Collection Summary

Description of Study Protocol. Data Collection Summary AND Evidence Analysis Worksheet Citation Kostoglou-athanassiou I, AthanassiouP, Lyraki A, Raftakis I, Antoniadis C. Vitamin D and rheumatoid arthritis. Ther Adv Endocrinol Metab. 2012; 3(6):181-7. Study

More information

Title: Cutaneous Adverse Drug Reactions in Indian population: A systematic review

Title: Cutaneous Adverse Drug Reactions in Indian population: A systematic review Title: Cutaneous Adverse Drug Reactions in Indian population: A systematic review Review question(s) To carry out a systematic review of the published evidence of the cutaneous adverse drug reactions in

More information

Identifying the comorbid conditions affecting Hemoglobin A1c levels of diabetes among African American population

Identifying the comorbid conditions affecting Hemoglobin A1c levels of diabetes among African American population Identifying the comorbid conditions affecting Hemoglobin A1c levels of diabetes among African American population Fakhrudin A. Mohamed, MD; Jason Kushner, MD, MS; Junita Jose (MSY3); Stephanie C. Clerge,

More information

Palliative Care Quality Improvement Program (QIP) Measurement Specifications

Palliative Care Quality Improvement Program (QIP) Measurement Specifications Palliative Care Quality Improvement Program (QIP) 2017-18 Measurement Specifications Developed by: QIP Team Contact: palliativeqip@partnershiphp.org Published on: October 6, 2017 Table of Contents Program

More information

Supplementary Tables. Psoriasis a

Supplementary Tables. Psoriasis a Supplementary Tables Supplementary Table S1 Age-sex distribution of patients with psoriasis and PPP subdivided by the department specified in a claim with a diagnosis code of psoriasis and PPP in Japanese

More information

SUMMARY OF CHANGES. Section : Site initiation Patients questionnaires, «including Qualisex (Ancillary study questionnaire- See Appendix 17.

SUMMARY OF CHANGES. Section : Site initiation Patients questionnaires, «including Qualisex (Ancillary study questionnaire- See Appendix 17. 31 July Addition of an ancillary study: Evaluation of Cimzia (Certolizumab pegol) SUMMARY OF CHANGES 1- Qualisex questionnaire Background: This ancillary study to ECLAIR is set up to measure the impact

More information

Research Notes from the Director

Research Notes from the Director Research Notes from the Director So far 2003 has been a very exciting and busy year. Earlier this spring, we presented NDB data at two meetings of the FDA. At the first meeting, NDB results for lymphoma,

More information

CHRONIC MEDICINE PROGRAMME: PICK N PAY PLUS OPTION - GENERAL INFORMATION LETTER

CHRONIC MEDICINE PROGRAMME: PICK N PAY PLUS OPTION - GENERAL INFORMATION LETTER CHRONIC MEDICINE PROGRAMME: PICK N PAY PLUS OPTION - GENERAL INFORMATION LETTER Prescribed Minimum Benefits The prescribed minimum benefits (PMBs) comprise a list of 270 conditions or group of conditions

More information

WARNING: RISK OF SERIOUS INFECTIONS

WARNING: RISK OF SERIOUS INFECTIONS RA PROGRESSION INTERRUPTED 1 DOSAGE AND ADMINISTRATION GUIDE No structural damage progression was observed at week 52 in 55.6% and in 47.8% of patients receiving KEVZARA 200 mg + MTX or 150 mg + MTX, compared

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Caduet) Reference Number: CP.CPA.237 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Medicaid Medi-Cal Revision Log See Important Reminder at the end of this policy

More information

Quantitative assessment of patients with rheumatic diseases

Quantitative assessment of patients with rheumatic diseases ORIGINAL ARTICLE Routine Assessment of Patient Index Data (RAPID3) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) Scores Yield Similar Information in 85 Korean Patients With Ankylosing

More information

Rheumatoid Arthritis. Manish Relan, MD FACP RhMSUS Arthritis & Rheumatology Care Center. Jacksonville, FL (904)

Rheumatoid Arthritis. Manish Relan, MD FACP RhMSUS Arthritis & Rheumatology Care Center. Jacksonville, FL (904) Rheumatoid Arthritis Manish Relan, MD FACP RhMSUS Arthritis & Rheumatology Care Center. Jacksonville, FL (904) 503-6999. 1 Disclosures Speaker Bureau: Abbvie 2 Objectives Better understand the pathophysiology

More information

T he treadmill exercise test is the classic initial investigation

T he treadmill exercise test is the classic initial investigation 1416 CARDIOVASCULAR MEDICINE Improving the positive predictive value of exercise testing in women Y K Wong, S Dawkins, R Grimes, F Smith, K D Dawkins, I A Simpson... See end of article for authors affiliations...

More information

Rheumatology function tests: Quantitative physical measures to monitor morbidity and predict mortality in patients with rheumatic diseases

Rheumatology function tests: Quantitative physical measures to monitor morbidity and predict mortality in patients with rheumatic diseases Rheumatology function tests: Quantitative physical measures to monitor morbidity and predict mortality in patients with rheumatic diseases T. Pincus Division of Rheumatology and Immunology, Department

More information

Affordability AMGA - MIPS Webinar

Affordability AMGA - MIPS Webinar Affordability AMGA - MIPS Webinar Beth Averbeck, MD Senior Medical Director Primary Care, HealthPartners Consumer-governed, non-profit HealthPartners Medical Group Primary Care: 500,000 patients 29 locations

More information

The Burden Report: Cardiovascular Disease & Stroke in Texas

The Burden Report: Cardiovascular Disease & Stroke in Texas The Burden Report: Cardiovascular Disease & Stroke in Texas Texas Cardiovascular Health and Wellness Program www.dshs.state.tx.us/wellness Texas Council on Cardiovascular Disease and Stroke www.texascvdcouncil.org

More information

10/17/2013. Billing and Coding in Long Term Care: Keeping the Wolves at Bay. Disclosure

10/17/2013. Billing and Coding in Long Term Care: Keeping the Wolves at Bay. Disclosure Billing and Coding in Long Term Care: Keeping the Wolves at Bay Maine Medical Directors Association Annual Conference October 11, 2013 Alva S Baker, MD, CMD-R Disclosure Dr. Baker has indicated that he

More information

Aspirin to Prevent Heart Attack and Stroke: What s the Right Dose?

Aspirin to Prevent Heart Attack and Stroke: What s the Right Dose? The American Journal of Medicine (2006) 119, 198-202 REVIEW Aspirin to Prevent Heart Attack and Stroke: What s the Right Dose? James E. Dalen, MD, MPH Professor Emeritus, University of Arizona, Tucson

More information

The Official Journal of the International Society of Pleural Diseases

The Official Journal of the International Society of Pleural Diseases The Official Journal of the International Society of Pleural Diseases Original Research Organizing a Dedicated Pleural Service at an Academic Center to Streamline Pleural Disease Care Aravind A. Menon

More information

CIHRT Exhibit P-2592 Page 1 APPENDIX. ADAPTE Process for the Treatment of In situ Breast Carcinoma. Eastern Health Breast Disease Site Group

CIHRT Exhibit P-2592 Page 1 APPENDIX. ADAPTE Process for the Treatment of In situ Breast Carcinoma. Eastern Health Breast Disease Site Group CIHRT Exhibit P-2592 Page 1 APPENDIX ADAPTE Process for the Treatment of In situ Breast Carcinoma Eastern Health Breast Disease Site Group Phase I - Setup The Breast Disease Site Group was formed in the

More information

CHRONIC MEDICINE PROGRAMME: GENERAL INFORMATION LETTER

CHRONIC MEDICINE PROGRAMME: GENERAL INFORMATION LETTER CHRONIC MEDICINE PROGRAMME: GENERAL INFORMATION LETTER The Prescribed Minimum Benefit Chronic Disease List In terms of the Medical Scheme Act Regulations that came into effect on 1 January 2004, Medical

More information

TENNCARE Bundled Payment Initiative: Description of Bundle Risk Adjustment for Wave 3 Episodes

TENNCARE Bundled Payment Initiative: Description of Bundle Risk Adjustment for Wave 3 Episodes TENNCARE Bundled Payment Initiative: Description of Bundle Risk Adjustment for Wave 3 Episodes Respiratory Infection (RI); Pneumonia (PNA); Inpatient Urinary Tract Infection (UTI-I; Outpatient Urinary

More information

Issue Brief. Eliminating Adult Dental Benefits in Medi-Cal: An Analysis of Impact. Introduction. Background

Issue Brief. Eliminating Adult Dental Benefits in Medi-Cal: An Analysis of Impact. Introduction. Background Eliminating Adult Dental Benefits in Medi-Cal: An Analysis of Impact Introduction In 2009, California eliminated non-emergency dental services for adults in its Medicaid program, Medi-Cal. The California

More information

b. To facilitate the management decision of a patient with an equivocal stress test.

b. To facilitate the management decision of a patient with an equivocal stress test. National Imaging Associates, Inc. Clinical guidelines EBCT HEART CT & HEART CT CONGENITAL CCTA CPT4 Codes: 75571 EBCT 75572, 75573 Heart CT & Heart CT Congenital 75574 - CCTA LCD ID Number: L33559 J K

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Actemra) Reference Number: HIM.PA.SP32 Effective Date: 05/17 Last Review Date: Line of Business: Health Insurance Marketplace Coding Implications Revision Log See Important Reminder at

More information

Submitted to: Re: Comments on CMS Proposals for Patient Condition Groups and Care Episode Groups

Submitted to: Re: Comments on CMS Proposals for Patient Condition Groups and Care Episode Groups April 24, 2017 The Honorable Seema Verma Administrator Centers for Medicare & Medicaid Services Hubert H. Humphrey Building 200 Independence Avenue SW Washington, D.C. 20201 Submitted to: macra-episode-based-cost-measures-info@acumenllc.com

More information

Your submission states that the adjusted indirect comparison methodology was based largely on the publication by Glenny et al

Your submission states that the adjusted indirect comparison methodology was based largely on the publication by Glenny et al Clarification of the indirect comparison Your submission states that the adjusted indirect comparison methodology was based largely on the publication by Glenny et al Your methodology is as follows: An

More information

Technology appraisal guidance Published: 26 July 2017 nice.org.uk/guidance/ta459

Technology appraisal guidance Published: 26 July 2017 nice.org.uk/guidance/ta459 Collagenase clostridium histolyticum for treating Dupuytren's contracture Technology appraisal guidance Published: 26 July 2017 nice.org.uk/guidance/ta459 NICE 2017. All rights reserved. Subject to Notice

More information

Prof. Dr. Gabor Ternak

Prof. Dr. Gabor Ternak Prof. Dr. Gabor Ternak Noninfectious diseases can't be passed from one person to another. Instead, these types of diseases are caused by factors such as the environment, genetics and lifestyle. The term

More information

LCD L B-type Natriuretic Peptide (BNP) Assays

LCD L B-type Natriuretic Peptide (BNP) Assays LCD L30559 - B-type Natriuretic Peptide (BNP) Assays Contractor Information Contractor Name: Novitas Solutions, Inc. Contractor Number(s): 12501, 12502, 12101, 12102, 12201, 12202, 12301, 12302, 12401,

More information

Case Study: Physician and Patient-Facing Medical Education APPs. Sandeep Pulim, MD Chief Medical Information Officer

Case Study: Physician and Patient-Facing Medical Education APPs. Sandeep Pulim, MD Chief Medical Information Officer Case Study: Physician and Patient-Facing Medical Education APPs Sandeep Pulim, MD Chief Medical Information Officer Quality IME Collaborating for Patient Care Commercial Supporter Medical Education Provider

More information

SYSTEMATIC REVIEWS OF TEST ACCURACY STUDIES

SYSTEMATIC REVIEWS OF TEST ACCURACY STUDIES Biomarker & Test Evaluation Program SYSTEMATIC REVIEWS OF TEST ACCURACY STUDIES Patrick MM Bossuyt Structure 1. Clinical Scenarios 2. Test Accuracy Studies 3. Systematic Reviews 4. Meta-Analysis 5.

More information